-
Sanofi Is Looking For Rare Disease Acquisitions, FT Says
Monday, February 29, 2016 - 10:21am | 220Sanofi SA (ADR) (NYSE: SNY) is actively looking to enter the rare disease drugs segment through an acquisition. The Financial Times reported on Sunday that David Meeker, head of Sanofi's Genzyme specialty care business, suggested that rare disease assets represent potential targets as the...